Tender Details

Country: USA
Summary: Notice of Intent to Award to Sole Source - 1ML Serum
UST Ref No: 106180560
Deadline: 29 Aug 2024
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: 85882
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
Description
•The Centers for Disease Control and Prevention (CDC) intends to award a sole source, firm fixed price contract to Creative Testing Solutions.
•This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 41 U.S.C. 3304(a)(1). The North American Industry Classification System code for this procurement is 325414 - Biological Product (except Diagnostic) Manufacturing. Interested persons may identify their interest and capability to respond to the requirement or submit proposals.
•This notice of intent is not a request for competitive proposals; however, all responses received within seven (7) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to the contract specialist Ruben Reyes at qmz3@cdc.gov by 12:00PM, August 29, 2024.
More Information:
•Serum from blood donations will be used to analyze from 3,000 donations across10 selected US States. Also obtained will be geographic and blood group information from respective blood collection organizations.
•The primary objectives of our project are to understand 1) the association between state of residence and presence of antibodies directed against alpha-gal and 2) to determine the association between blood type and the presence of antibodies directed against alpha-gal. To meet these objectives, we require blood donor specimens that are 1) nationally representative, 2) from blood donors for whom the zip code of residence is known 3) for whom the blood type is known. Serum specimens provided through Clinical Testing Solutions...
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Notice of Intent to Award to Sole Source - 1ML Serum - USA Tender

The HEALTH AND HUMAN SERVICES, DEPARTMENT OF | CENTERS FOR DISEASE CONTROL AND PREVENTION, a Government sector organization in USA, has announced a new tender for Notice of Intent to Award to Sole Source - 1ML Serum. This tender is published on USARFP under UST Ref No: 106180560 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-08-29.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.